In 2018 PriMed Initiated Collaboration in Ophthalmology with Harvard Mass. Eye and Ear.
In 2018 Harvard Mass. Eye and Ear. and PriMed Bio-tech Group Co., Ltd, a leading science-driven, technologically advanced, high-quality preclinical research partner, initiated collaboration in ophthalmology in PriMed NHP colony.
The Successful 3-year On-site Review of AAALAC Certification
On March 5, 2018, PriMed Bio-tech Group Co., Ltd, a leading science-driven, technologically advanced, high-quality preclinical research partner, received the 3-year on-site review from the Association for the Assessment and Accreditation
Primed is a Cutting Edge Translational Research Company devoted to understanding and overcoming human diseases.
Primed has extensive expertise and significant experience in non-human primate research, as well as identifying and developing specialized animal models of human disease, helping global biomedical research community solve challenges in Metabolic disease, Eye disease, Cardiovascular diseases, NAFLD/NASH, Autoimmune diseases and Kidney disease.
Primed's research facilities are AAALAC accredited and GLP compliant, providing expertise from disease model validation to IND-enabling study design and execution for over 100 global partners.
Primed has well-established multi-modality imaging capabilities and extensive expertise in developing and applying imaging biomarkers for drug discovery and development with 11 different imaging modalities available for studies.
